UnitedHealth – Earlybirds Invest https://earlybirdsinvest.com Latest Crypto News Mon, 08 Sep 2025 14:27:54 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.7 https://i0.wp.com/earlybirdsinvest.com/wp-content/uploads/2024/12/cropped-New-Project-2024-12-17T235703.455.png?fit=32%2C32&ssl=1 UnitedHealth – Earlybirds Invest https://earlybirdsinvest.com 32 32 240146708 Berkshire Hathaway Buys UnitedHealth Shares: Should You Follow Suit? https://earlybirdsinvest.com/berkshire-hathaway-buys-unitedhealth-shares-should-you-follow-suit/ https://earlybirdsinvest.com/berkshire-hathaway-buys-unitedhealth-shares-should-you-follow-suit/#respond Mon, 08 Sep 2025 14:27:53 +0000 https://earlybirdsinvest.com/berkshire-hathaway-buys-unitedhealth-shares-should-you-follow-suit/ The Oracle of Omaha’s Berkshire Hathaway is buying into troubled UnitedHealth.

For decades, UnitedHealth Group (UNH -0.40%) could do no wrong. The company raised its dividend by an exceptional 7,266% from 2010 to 2025, while shares rose as much as 1,700% during this run.

But shares have fallen roughly 40% year to date as the company faces a host of problems, from the murder of Brian Thompson, CEO of major business segment UnitedHealthcare, to federal investigations into allegedly fraudulent Medicare billing practices.

Nonetheless, shares surged 12% on Aug. 14 after filings revealed Berkshire Hathaway had bought over 5 million shares.

Berkshire’s move was seen as a major vote of confidence in the stock — and investors joined a stampede to follow Warren Buffett into the trade. Should you?

A doctor and patient talk across the doctor's desk.

Image source: Getty Images.

Big growth potential for all segments

UnitedHealth operates through four segments. Its UnitedHealthcare segment provides consumer-oriented health benefit plans and services for employers. Optum Health provides healthcare management and financial services, while Optum Insight offers data analysis tools, consulting, and tech solutions to healthcare providers. Optum Rx is a direct-to-consumer platform offering pharmacy services and 190 million prescriptions per year to U.S. homes.

In its second-quarter report on July 29, the company reported quarterly revenue of $111.6 billion, up roughly 13% from the year-ago period. The trouble is with margins. For UnitedHealthcare, the biggest segment, operating margin fell from 6.2% in Q1 2025 to 2.4% last quarter. Combined, margin for the three Optum segments fell from 6.1% in Q1 2025 to 4.6% in Q2.

These declines are steep enough that, even with revenue on the upswing, earnings fell from $9.1 billion in Q1 2025 to $5.2 billion last quarter.

Rising medical costs are the chief headwind. In the July earnings report, new CEO Stephen Hensley acknowledged that UNH “significantly underestimated the accelerating medical trend,” and medical costs totaled $6.5 billion more than anticipated.

But management is under no such illusions now. They’re taking actions to boost efficiency and cut waste, from stepping up audits of clinical policy and payment integrity tools, to scaling artificial intelligence (AI) efforts to improve provider and patient experiences while driving down costs. Implementation of AI technologies is part of initiatives the company hopes can deliver almost $1 billion in cost reductions. Perhaps most significantly, the company is raising premiums after saying it underpriced Medicare Advantage plans in 2025.

In the meantime, each of these segments could grow significantly in the years ahead. UnitedHealthcare Employer & Individual just rolled out services in its 30th state, while Optum Rx’s growth outlook is 5%-8% annually. Optum Insight is targeting operating margin of 18%-22%, while the 4.7 million patients receiving value-based care from OptumHealth represent only a fraction of the nearly 340 million Americans who could fall under its 100-plus health plans.

It’s not just Berkshire buying

Berkshire Hathaway’s move in UnitedHealth is getting headlines. But billionaire David Tepper also scooped up 2.3 million shares, while Michael Burry of The Big Short fame bought 350,000 call options on the stock in a bet that shares would rise.

In addition, BlackRock, the world’s biggest asset manager, bought over 1 million shares last quarter. Goldman Sachs bought over 1.1 million shares, while Renaissance Technologies (the fabled fund that achieved an average annual return of 66% for decades) bought over 1.35 million.

As for management, Stephen Hensley invested $25 million just days after becoming CEO, while the company’s CFO bought another $5 million worth in shares. All told, the insider buying of UNH stock outweighed insider selling by a nearly 4:1 margin last quarter.

As the investing legend Peter Lynch observed, insiders can sell for many reasons unrelated to a stock. But they buy for only one: They think shares will go up.

Why UnitedHealth is a buy for retail investors, too

Berkshire officials haven’t commented publicly on their rationale for buying UnitedHealthcare, but it’s possible to speculate on their reasons.

Warren Buffett has called cash flow the most important metric in assessing a business’s potential. In a 2000 letter to shareholders, he wrote that dividend yield, the price-to-earnings ratio, book value, and even growth rates “have nothing to do with valuation except to the extent they provide clues to the amount and timing of cash flows into and from the business.”

Positive cash flow shows the company can cover its obligations, return money to shareholders, and potentially pursue growth and expansion. After floundering in 2024, UnitedHealth’s trailing-12-month operating cash flow has rebounded to $29 billion compared to $24.2 billion at the end of last year.

And if price-to-earnings, dividend yield, and growth rates are only background clues to cash flow, these metrics seem to bode well for UnitedHealth, too.

The company’s price-to-earnings ratio of 13.7 is cheap compared to the S&P 500,
with its average P/E ratio of around 26, while revenue growth of 13% year over year further fuels the bull case. Meanwhile, the company’s recent 5.2% dividend increase — its 15th consecutive annual payout hike — brings its yield to 2.8% as I write this, nearly triple the S&P 500 average.

For investors willing to take a long-term approach and be rewarded with rising income in the meantime, UnitedHealth is a buy.

]]>
https://earlybirdsinvest.com/berkshire-hathaway-buys-unitedhealth-shares-should-you-follow-suit/feed/ 0 57401
UnitedHealth Stock Crash: 3 Better Dow Jones Dividend Stocks to Buy Now https://earlybirdsinvest.com/unitedhealth-stock-crash-3-better-dow-jones-dividend-stocks-to-buy-now/ https://earlybirdsinvest.com/unitedhealth-stock-crash-3-better-dow-jones-dividend-stocks-to-buy-now/#respond Wed, 23 Apr 2025 20:29:15 +0000 https://earlybirdsinvest.com/unitedhealth-stock-crash-3-better-dow-jones-dividend-stocks-to-buy-now/

After UnitedHealth Group (UNH 0.25%) delivered a surprisingly weak first-quarter report last Thursday, its stock price crashed more than 22% on Friday — the insurer’s worst single-session drop since August 1998. Prior to that sell-off, UnitedHealth was the largest component in the price-weighted Dow Jones Industrial Average (^DJI 1.07%). Now, the baton has been passed to Goldman Sachs.

Numerous top Dow holdings have sold off considerably this year, pushing the index into correction territory — defined as a decline of at least 10% from a recent high. In fact, the Dow, S&P 500, and Nasdaq Composite are all currently in correction territory.

Despite UnitedHealth’s dramatic sell-off, there are arguably better Dow dividend stocks to buy now. In particular, Visa (V 1.05%), Chevron (CVX -0.36%), and Procter & Gamble (PG -1.27%) are worth a closer look.

A person sitting in an urban setting smiles while holding their phone and a payment card.

Image source: Getty Images.

Visa’s competitive advantages shine no matter the economic backdrop

Payment processor Visa collects fees every time credit or debit cards issued through its network are swiped, tapped, or digitally utilized. Like Mastercard, Visa partners with financial institutions that bear the credit risk in exchange for generating interest income on borrowers’ outstanding balances.

Visa’s scale is truly unmatched in its space, and it has grown steadily over the years. The higher its transaction volume and frequency, the more fees it collects.

Visa has very low operating expenses. In fact, its operating margin is 66.2% and its profit margin is a staggering 54.3% — it’s converting over half of its revenue into pure profit.

One advantage of Visa’s business model compared to other financial services companies is that it can still generate substantial profits even during an economic slowdown or recession. Growth may slow to a halt, but it can still generate sufficient funds to cover its dividend, repurchase stock, and reinvest in the business. Visa’s payout at the current share price only yields 0.7% because the company spends significantly more on stock buybacks than dividends. Those appear to have been a better use of capital over time, given the stock’s strong performance. If it were to devote its entire capital return program to dividends alone, Visa’s payout would yield over 3%.

American Express has arguably more upside potential, but Visa is an ultra-safe Dow stock that investors can be confident buying even if the stock market’s broad downturn persists.

Chevron combines dividend reliability with a high yield

Chevron’s dividend yield of 5% at the current share price makes it the second-highest yielding Dow component, behind only Verizon Communications. The integrated oil and natural gas major has a track record of 38 consecutive years of payout increases, despite industrywide downturns and economic slowdowns along the way.

Chevron and the broader energy sector have been selling off in 2025 due to falling oil and natural gas prices, which are down due to concerns about President Donald Trump’s trade war, which has forecasters expecting weaker demand growth for oil amid macroeconomic headwinds, even as the OPEC+ group moves ahead with production hikes.

Given these risks, investors may wonder why Chevron is a worthwhile investment at this time. The investment thesis can be boiled down to three factors.

The first is that its dividend offers a sizable incentive to buy and hold the stock over the long term. Second, Chevron has an impeccable balance sheet with low long-term debt and leverage, providing it with a cushion in the event of a prolonged downturn. Finally, Chevron has made improvements to its operating structure over the years by reducing production costs and investing in high-margin plays such as the Permian Basin. Chevron delivered the first oil from its expansion project in Kazakhstan earlier this year and is expanding operations offshore the Gulf of Mexico. Chevron has a geographically diverse production portfolio, as well as a sizable refining business and a growing low-carbon business.

The stock is down by 16% over the last month, and that sell-off is certainly a buying opportunity for income investors.

A safe stock for risk-averse investors

Procter & Gamble and the consumer staples sector have thus far withstood the broader stock market sell-off well. During times of economic uncertainty, investors tend to flock to consumer staples companies for their steady results and reliable dividends. Consumers are less likely to cut their spending on products like toothpaste and dish soap than they are on discretionary goods and services, making companies like P&G safe bets regardless of the economy’s state.

P&G has considerable international exposure due to its complex supply chain and distribution network, which make it somewhat vulnerable to tariffs, trade wars, and foreign currency fluctuations. However, the company has historically been able to pass along its higher costs to consumers via price hikes thanks to its size and product mix, which give it operating leverage compared to competitors.

P&G will report its fiscal 2025 third-quarter earnings on Thursday. Investors should be on the lookout for management commentary on tariffs and China. In fiscal Q2, P&G improved its results in Greater China, but it wouldn’t be surprising if its business in the region has taken a step back due to the intensified trade war.

With 69 consecutive years of dividend increases and a 2.5% yield, P&G is the ultimate safe stock for investors to consider now. However, its valuation is somewhat expensive at 27.2 times earnings, so investors should only buy it if they are willing to pay a premium price.

American Express is an advertising partner of Motley Fool Money. Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Chevron, Goldman Sachs Group, Mastercard, and Visa. The Motley Fool recommends UnitedHealth Group and Verizon Communications. The Motley Fool has a disclosure policy.

]]>
https://earlybirdsinvest.com/unitedhealth-stock-crash-3-better-dow-jones-dividend-stocks-to-buy-now/feed/ 0 32443